StarchLite® is a natural and proprietary aqueous extract of white bean (Phaseolus vulgaris) clinically proven to reduce the GI of starchy foods through 5 clinical studies carried out on 85 subjects. It acts as a temporary inhibitor of alpha-amylase which is the enzyme responsible for the breakdown of complex carbohydrates into simple sugars that can be quickly absorbed by the organism. Thanks to StarchLite, part of ingested starchy food is not digested into available simple sugars and thus is not absorbed. Starchlite mechanism of action enables the reduction of both the glycemic index and the caloric impact of starchy foods making it an efficient partner for weight management.
StarchLite® also benefits from 2 US health claim authorizations validated by the FDA:
- “May reduce enzymatic digestion of dietary starch”
- “May assist in weight control when used in conjunction with a sensible diet and exercise program”
Ingredia Nutritional is PharmaChem Laboratories’ partner for the distribution of StarchLite® in Asia and Europe.